Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 3/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.50 |
| ▸ | RARB | P10826 | 1/20 | 0.49 |
| ▸ | RARG | P13631 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 3/20 | 0.44 |
| ▸ | RXRB | P28702 | 3/20 | 0.44 |
| ▸ | RXRG | P48443 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9178487 | 0.84 | SRD5A2 (0.57) | SRD5A2EPHX2NR1H4RARBRARG | |
| SCHEMBL4861421 | 0.84 | SRD5A2 (0.57) | SRD5A2EPHX2NR1H4RARBRARG | |
| SCHEMBL3241556 | 0.84 | SRD5A2 (0.61) | SRD5A2EPHX2RARBRARGTP53 | |
| SCHEMBL18130711 | 0.80 | SRD5A2 (0.57) | SRD5A2EPHX2NR1H4RARBRARG | |
| SCHEMBL10013563 | 0.80 | SRD5A2 (0.57) | SRD5A2EPHX2NR1H4RARBRARG | |
| SCHEMBL4131036 | 0.79 | SRD5A2 (0.61) | SRD5A2EPHX2NR1H4RARBRARG | |
| SCHEMBL16429445 | 0.79 | SRD5A2 (0.61) | SRD5A2EPHX2RARBRARGTP53 | |
| SCHEMBL107327 | 0.79 | SRD5A2 (0.61) | SRD5A2EPHX2NR1H4RARBRARG | |
| SCHEMBL30144875 | 0.79 | SRD5A2 (0.61) | SRD5A2EPHX2RARBRARGTP53 | |
| SCHEMBL2058451 | 0.78 | SRD5A2 (0.55) | SRD5A2EPHX2RARBRARGTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100545140-C | High-purity (fluoroalkyl) benzene derivative and preparation method thereof | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-09-30 | — | — | CN | disclosed |
| US-7405331-B2 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| US-20060167324-A1 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-07-27 | — | — | US | disclosed |
| CN-1653029-A | High-purity (fluoroalkyl) benzene derivative and preparation method thereof | MITSUBISHI GAS CHEMICAL CO (JP) | 2005-08-10 | — | — | CN | disclosed |
| EP-1500641-A1 | HIGH-PURITY (FLUOROALKYL)BENZENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167324-A1 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | HBB, AFF4, AFF2 | SRD5A2 2791/4885EPHX2 308/4885NR1H4 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.